Related Experiment Videos
Loop diuretic therapy in acute and chronic renal failure
1Renal Unit, Glasgow Royal Infirmary, Scotland.
Journal of Cardiovascular Pharmacology
|January 1, 1993
Summary
Loop diuretics, including torasemide, have improved quality of life for chronic renal failure (CRF) patients. This review examines torasemide
Area of Science:
- Nephrology
- Pharmacology
Background:
- Loop diuretics have advanced significantly over 30 years.
- Torasemide is the most recent powerful loop diuretic.
- Chronic renal failure (CRF) management has improved.
Observation:
- This review details torasemide's mechanism of action.
- Pharmacokinetics and pharmacodynamics of torasemide in CRF are discussed.
- Efficacy and utility in CRF, dialysis, and nephrotic syndrome are reviewed.
Findings:
- Torasemide's role in acute renal failure is currently unknown.
- Theoretical benefits of loop diuretics in acute renal failure are presented.
- Current knowledge and an ongoing study on loop diuretics in acute renal failure are outlined.
Implications:
- Loop diuretics offer potential benefits for CRF patients.
- Further research is needed to clarify the role of loop diuretics in acute renal failure.
- Torasemide shows promise in managing renal conditions.